BKKT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Bakkt Inc is not a good buy right now for a beginner long-term investor with $50,000-$100,000 ready to deploy. The stock has some speculative upside, but the current setup is not strong enough to justify an immediate long-term buy. The price is sitting near pivot support with neutral momentum, no strong buy signal from Intellectia, weak recent financial results, and no supportive news catalyst. If the investor is impatient and wants to act now, the better call is to hold rather than buy.
BKKT is trading at 8.65 after closing near 8.55, which is just above the pivot level of 8.582. RSI_6 at 43.659 is neutral and does not show a strong oversold bounce setup. The MACD histogram is positive at 0.0414, but it is contracting, which suggests bullish momentum is fading rather than accelerating. Moving averages are converging, indicating a range-bound and indecisive trend. Support is near 7.999 and 7.639, while resistance sits at 9.164 and 9.524. Overall, the chart shows a weakly constructive but not convincing trend.
["Bullish options sentiment with very low put-call ratios", "Clear Street and Benchmark both kept Buy ratings despite cutting price targets", "Investor Day narrative highlights a transition toward digital asset infrastructure and programmable finance", "Upcoming QMar 2026 earnings on 2026-05-11 could act as a catalyst", "The stock is near pivot support, which may offer a technically reasonable entry area"]
["No news in the recent week, so there is no fresh catalyst from company developments", "Revenue in 2025/Q4 dropped sharply by 82.89% YoY", "Gross margin deteriorated significantly, pointing to weak operating quality", "Net income remains negative at -85.27M", "Analysts sharply reduced price targets from $39 to $21 and from $40 to $22", "No significant insider or hedge fund accumulation trend", "No recent congress trading data available"]
In 2025/Q4, Bakkt reported revenue of 299.173M, down 82.89% year over year, which is a very steep decline and the biggest concern in the latest quarter. Net income was -85.27M, still negative, although the year-over-year comparison improved. EPS was -3.87, also still negative. Gross margin fell to 1.08, showing very weak profitability quality. For a long-term beginner investor, these results do not yet support a confident buy thesis.
Recent analyst sentiment remains positive in rating but weaker in valuation expectations. On 2026-03-18, Benchmark lowered its price target to $22 from $40 and kept a Buy rating. On 2026-03-19, Clear Street lowered its target to $21 from $39 and also kept a Buy rating. The Wall Street pros view is therefore mixed: they still like the strategic transformation story and long-term platform potential, but the rapid cuts to price targets show reduced conviction in near-term upside. This makes the stock more of a speculative hold than a high-conviction buy.
